Cargando…
Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4(+) T Cells in Children With Acute Kawasaki Disease
BACKGROUND: Intravenous immunoglobulin (IVIG) showed its therapeutic efficacy on Kawasaki disease (KD). However, the mechanisms by which it reduces systemic inflammation are not completely understood. Dendritic cells (DCs) and T cells play critical roles in the pathogenic processes of immune disorde...
Autores principales: | Wang, Nana, Chen, Zhongyue, Zhang, Fan, Zhang, Qianwen, Sun, Ling, Lv, Haitao, Wang, Bo, Shen, Jie, Zhou, Xufang, Chen, Feiyan, Zhang, Binwei, Meng, Lijun, Zhou, Huiting, Bai, ZhenJiang, Huang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866170/ https://www.ncbi.nlm.nih.gov/pubmed/35222381 http://dx.doi.org/10.3389/fimmu.2022.802690 |
Ejemplares similares
-
Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023) -
Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022) -
Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022) -
Bioinformatics identification of hub genes and signaling pathways regulated by intravenous immunoglobulin treatment in acute Kawasaki disease
por: Huang, Hongbiao, et al.
Publicado: (2021) -
Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)